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The higher the proportion of a T-cell subset (CD4 + Vα2.3 + T-cells) in bronchoalveolar lavage fluid of sarcoidosis patients, the better the prognosis and therefore it may be used as an additional prognostic tool http://bit.ly/2Mta0Cs This single-page version can be shared freely online.
To the Editor:
Sarcoidosis is characterised by an accumulation of CD4 + T-cells in the lungs and an increased bronchoalveolar lavage fluid (BALF) CD4/CD8 ratio (>3.5) [1] . In sarcoidosis, an expansion of BALF CD4 + T-cells expressing the T-cell receptor Vα2.3 has been associated with good prognosis and with specific HLA-alleles, i.e. HLA-DRB1*0301 and HLA-DRB3*0101 (which is often carried together with HLA-DRB1*13). HLA-DRB1*03 and HLA-DRB3*0101 molecules show similarities in the region important for antigen presentation and both may therefore be capable of presenting identical antigens to the lung T-cells [2] . Furthermore, an expansion defined as >10.5% CD4 + Vα2.3 + BALF T-cells is commonly seen in patients with Löfgren's syndrome [3] , which is characterised by an acute onset with bilateral ankle arthritis and/or erythema nodosum, bilateral hilar lymphadenopathy and, in some cases, with parenchymal infiltrates and usually fever [4] . We have previously shown that very high expansions of CD4 + Vα2.3 + T-cells are associated with Löfgren's syndrome and a disease duration <2 years [3] . However, not all patients with an expansion of CD4 + Vα2.3 + T-cells have Löfgren's syndrome and resolving disease. In this much enlarged study on a HLA-typed sarcoidosis cohort, we aimed at investigating the clinical characteristics of patients with an expansion of CD4 + Vα2.3 + T-cells in BALF and to analyse if the degree of expansion may predict the prognosis of sarcoidosis.
